MB310

· Microbiotica Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MB310, covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1b Trial to Evaluate the Safety of MB310 in Patients With Active, Mild-to-Moderate Ulcerative Colitis [Phase 1]

See pricing